The mammalian renal toxicant tetraf luoroethylcysteine (TFEC) is metabolized to a reactive intermediate that covalently modifies the lysine residues of a select group of mitochondrial proteins, forming dif luorothioamidyl lysine protein adducts. Cellular damage is initiated by this process and cell death ensues. NH 2 -terminal sequence analysis of purified mitochondrial proteins containing dif luorothioamidyl lysine adducts identified the lipoamide succinyltransferase and dihydrolipoamide dehydrogenase subunits of the ␣-ketoglutarate dehydrogenase complex (␣KGDH), a key regulatory component of oxidative metabolism, as targets for TFEC action. Adduct formation resulted in marked inhibition of ␣KGDH enzymatic activity, whereas the related pyruvate dehydrogenase complex was unmodified by TFEC and its activity was not inhibited in vivo. Covalent modification of ␣KGDH subunits also resulted in interactions with mitochondrial chaperonin HSP60 in vivo and with HSP60 and mitochondrial HSP70 in vitro. These observations confirm the role of mammalian stress proteins in the recognition of abnormal proteins and provide supporting evidence for reactive metabolite-induced cell death by modification of critical protein targets.
Mitochondrial stress proteins perform many vital functions including the import, folding, and assembly of newly synthesized polypeptides (1) (2) (3) . Genetic studies have clearly indicated that the 60-kDa heat shock protein (HSP60) and the mitochondrial 70-kDa heat shock protein (mtHSP70) are essential for yeast viability (4, 5) . Crystal structures of prokaryotic homologs, GroEL and DnaK͞peptide-binding domain, have recently been determined, largely defining their structure and function (6, 7) . It is anticipated that eukaryotic HSP60 and mtHSP70 will resemble the prokaryotic forms and also function in abnormal fold state recognition, prevention of aggregation, and other ''downstream'' processes of organellar removal and degradation (8) (9) (10) . To date, detailed functional studies of HSP60 and mtHSP70 in mammalian systems have been limited and information is only now beginning to emerge (11) .
The nephrotoxicant S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC) is a metabolite of the industrial gas tetrafluoroethene and is representative of several structurally related halogensubstituted gases with broad economic and environmental interest. These include inhalational anesthetics (e.g., halothane and sevoflurane), ozone-depleting chlorofluorocarbon substitutes, and other industrial gases (12) (13) (14) . According to the covalent binding hypothesis of cell damage, first proposed more than 20 years ago (15, 16) , the bioactivation of an otherwise chemically inert compound will result in generation of reactive intermediates that covalently modify critical cellular targets. Such proteotoxic processes are believed to result in an inactivation of target protein function and, ultimately, cell death and organ damage (17) . Consequently, the presence of covalently bound protein adducts after drug or chemical exposure is used extensively to indicate a potential for toxic reactions, although the nature of critical protein target(s) has yet to be defined for any compound. TFEC represents a prototypical compound for examining such processes with enzymatic bioactivation that results in the formation of a reactive acyl fluoride species that covalently modifies lysine -amino groups to form difluorothioamidyl lysine (DFTAL) protein adducts (14) .
Nephrotoxic doses of TFEC reproducibly modify five major proteins in rat kidney mitochondria with approximate molecular masses of 99, 84, 66, 52, and 48 kDa (18) . We have previously shown that the prominently adducted 66-kDa and 84-kDa proteins are, respectively, chaperonin HSP60 and mtHSP70 (also known as the 74-kDa peptide-binding protein or mortalin; refs. [19] [20] [21] . In addition, we identified a minor 42-kDa DFTAL-modified protein as the mitochondrial isoform of aspartate aminotransferase. Independent studies have subsequently shown that aspartate aminotransferase activity is decreased after DFTAL formation (22) . We report herein the identification of additional TFEC target proteins, further studies outlining the molecular events associated with this form of cell death, and discuss implications for the covalent binding hypothesis and the actions of mammalian stress proteins.
tained from two independent F344 rat mitochondrial preparations. Renal tissue protein was isolated 6 h after TFEC (30 mg͞kg) was administered i.p. and purified DFTAL proteins were subject to replicate NH 2 -terminal sequence analyses, as described (18) , before confirmation of target protein adduction using immunoprecipitation. Homology searches were as described (18) . Amino acid residues are numbered from the translational initiation codon for the published lipoamide succinyltransferase (E2 o ) or dihydrolipoamide dehydrogenase (E3 o ) sequences (25) (26) (27) .
␣-Ketoglutarate Dehydrogenase (␣KGDH) and Pyruvate Dehydrogenase (PDH) Complex Activities. ␣KGDH activities were determined from homogenized kidney tissue by measuring the formation of NADH by monitoring absorbance at 340 nm as described (28) . Potential inhibition of ␣KGDH activity by TFEC was assessed with porcine heart ␣KGDH and found not to be inhibited directly (data not presented). PDH activities were determined by coupling the generation of NADH to the oxidation of 2-(p-iodophenyl)-3-p-nitrophenyl-5-phenyltetrazolium chloride (INT) (29) .
Assessment of Renal Function. Urinary glucose and blood urea nitrogen levels were determined at regular intervals after administration of TFEC (30 mg͞kg, i.p.) by using commercially available diagnostic kits.
Immunohistochemistry. Rats were treated with TFEC (30 mg͞kg, i.p.) and sacrificed at regular intervals after dosing. Kidneys were decapsulated, fixed in neutral buffered formalin, and embedded in paraffin. After deparaffination, sections were stained immunohistochemically for DFTAL-modified proteins as described (24) .
Immunoprecipitation and Immunoblots. Immunoprecipitations from tissue homogenates or in vitro-generated samples were performed as described by using 5 l of HSP60 mAb Immunoprecipitates were separated on denaturing polyacrylamide gels (SDS͞PAGE) and subjected to fluorography and autoradiography to detect radiolabeled proteins or to enhanced chemiluminescence after transfer to nitrocellulose (ECL, Amersham).
Isolation of Mitochondria and in Vitro Incubation Conditions. Kidney mitochondria were isolated from untreated F344 rats as described (18) . Tissue homogenates from control or TFEC-treated animals (30 mg͞kg, i.p.; 6 h) were used immediately for immunoprecipitation (see Fig. 2 ) or for the preparation of mitochondria (control animals only) (see Figs. 3 and 4) . Cytosolic contamination of mitochondria, as judged by residual lactate dehydrogenase activity, was typically 10-15%. Isolated mitochondria were incubated with either unlabeled TFEC (100 or 500 M) or [ 35 S]TFEC (80 or 400 M) for 1 h at 25°C before examination by immunoblot analysis or autoradiography. Mitochondria were incubated in isolation buffer not containing ADP in the absence or the presence of 10 mM aminooxyacetic acid. For studies examining the effect of ATP on complex formation, mitochondria were incubated in isolation buffer containing 1 mM ATP.
Statistical Analysis. Analysis of variance used the Bonferroni͞Dunn post hoc test with STATVIEW (Abacus Concepts, San Francisco, CA). Statistical significance was assumed when the P value was Ͻ0.01. All data are presented as mean Ϯ SEM.
RESULTS AND DISCUSSION
To identify the 48-kDa and 52-kDa DFTAL proteins, we partially purified these proteins while monitoring for adduct localization (18 The functional consequence of covalent modification was assessed by determining the in vivo activity of the ␣KGDH complex after a nephrotoxic dose of TFEC. As an internal control for mitochondrial damage, the activity of the functionally related PDH multienzyme complex was also examined. The data confirmed that in vivo ␣KGDH activity was significantly inhibited, whereas PDH activity was not inhibited (Fig.  1A ). Maximal ␣KGDH inhibition was observed 12 h after TFEC administration and declined to 45% of the activity of untreated controls (P Ͻ 0.001). The time course and extent of ␣KGDH inhibition was consistent with the relative number of immunohistochemically labeled target cells (i.e., protein covalent binding) (Fig. 1C) . Maximal inhibition of ␣KGDH activity preceded peak renal damage at 24 h, as assessed by other biochemical and morphological indices ( Fig. 1 B and C) . In addition, loss of ␣KGDH activity was marginally significant (P ϭ 0.016) as early as 6 h after TFEC administration. Subsequent time points indicated a return of ␣KGDH activity and, although not significant, still represented an approximately 25% inhibition of control levels ( Fig. 1 A) .
Our data confirm that DFTAL formation on the E2 o and E3 o subunits of ␣KGDH in vivo resulted in a pronounced inhibition of ␣KGDH activity. Earlier studies have shown an inhibition of the ␣KGDH complex after TFEC treatment but it has not been possible to determine from these studies whether this was a direct or an indirect effect (30, 31) . Furthermore, we did not observe any decreases in PDH activity after TFEC treatment, indicating that the functionally and structurally related PDH complex was not a primary target for TFEC in vivo.
An expected repercussion of ␣KGDH covalent modification and inactivation would be the perturbation of subunit structure resulting in mitochondrial stress protein recognition (6, 8, 9) . To test this, HSP60 and associated proteins were immunoprecipitated directly from untreated or TFEC-treated tissue homogenates (Fig. 2) . HSP60 complexes were then immunoblotted with monospecific antiserum for each ␣KGDH subunit ( Fig. 2 A and B and ref. 32) . Similarly, ␣KGDH subunitdirected immune complexes were immunoblotted with HSP60 mAb (Fig. 2C) . In both cases HSP60 was only found associated with ␣KGDH subunits after TFEC treatment, confirming that chaperonin recognition of ␣KGDH subunits occurs after the proteotoxic event (Fig. 2 A-C) . HSP60 localization with the E1 o subunit suggested that E1 o is released from the ␣KGDH complex, thereby revealing normally inaccessible hydrophobic stretches required for HSP60 binding (Fig. 2C and ref. 6 ). We also examined potential HSP60 interactions with PDH subunits and found no comparable association (data not presented).
To exclude nonspecific HSP60 interactions with the intact complete ␣KGDH complex, we examined E1 o , E2 o , and E3 o immunoprecipitations for other ''contaminating'' subunits ( Fig. 2 D and E) . Although we were unable to detect E1 o by immunoprecipitation under these conditions, we were able to confirm that E2 o and E3 o immunoprecipitations were very selective in precipitating the subunit of interest (Fig. 2 D and  E) . Lack of E1 o detection, in these experiments, may be due to the decreased immunoreactivity of E1 o -directed antiserum to fragments of this proteolytically sensitive subunit. Overall, these data indicated that increased HSP60 binding to individual ␣KGDH subunits was related to toxicant-mediated changes to these subunits and the ␣KGDH complex.
We independently confirmed the in vivo data of ␣KGDH adduct localization by incubating normal rat mitochondria with [ (Fig. 3) and using subunit-specific antibodies to immunoprecipitate radiolabeled subunits (Fig. 4) . Isolated mitochondria were incubated with [ Fig. 3B ). Although the pattern of radiolabeled proteins was similar to that found with DFTALdirected antiserum, considerable differences in band intensity between these two techniques were observed (Fig. 3B) . A lack of agreement between immunochemical and radiochemical procedures has been observed previously with other studies that have compared protein adduct localization by both techniques (34) .
Mitochondrial incubations with higher concentrations of unlabeled TFEC (500 M) generated a pattern similar to that observed in vivo (Fig. 3C Left, compare with Fig. 3A) . Analogously, 35 S-labeled proteins from incubations with 400 M [ 35 S]TFEC were nearly identical to those observed in vivo above 35-kDa molecular mass (Fig. 3C Middle, compare with  Fig. 3A) . The more complex pattern of radiolabeled proteins at lower mass is suggestive of protein degradation. In all cases, the addition of aminooxyacetic acid (35), a specific inhibitor of TFEC bioactivation by ␤-lyase, completely inhibited 35 Slabeling or immunoreactivity, confirming that ␤-lyase was required for these protein modification events (Fig. 3 B Right and C Right). We concluded that in vitro incubations of normal isolated mitochondria with [ Increases in urinary glucose concentration (ᮀ), an early indicator of renal damage, paralleled the onset of cell death (C) and preceded increased blood urea nitrogen levels (F) (n ϭ 4 or 5, from one determination). Variance is less than symbol width when not visible. (C) Immunohistochemical localization of protein adducts in renal tissue using DFTAL-specific antiserum after TFEC treatment. Immunoreactivity was evident as early as 6 h after the dose was administered as punctate staining of mostly S3C proximal tubule epithelial cells (arrows). Staining was qualitatively maximal at 12 h in both S3C and S3M proximal tubule segments. Medullary ray (MR) and glomerular (G) structures remained unstained. Proximal tubule cell death, visualized as an exfoliation into the tubule lumen, was maximal between 18 and 48 h after the dose was administered. Immunoreactive cell debris was cleared progressively and was localized exclusively to the lumen by 72 h. ( (36, 37) .
Immunoprecipitation of radiolabeled HSP60 from in vitro mitochondrial incubations was in accord with the in vivo data showing that HSP60 was a primary target and that it coprecipitated with other DFTAL proteins (Fig. 4C and ref. 18) . In contrast to E2 o and E3 o immunoprecipitates, however, the extent of radiolabel on HSP60 per se was consistently lower compared with other coprecipitating [ 35 S]DFTAL proteins (Fig. 4C, compare with Fig. 4 A and B) . This preferential enrichment of other [ (Fig. 4C) . Total radiolabeled proteins coprecipitating with HSP60 were further decreased, but not abolished, when mitochondria were incubated in the presence of added ATP and ATP-generating substrates (Fig.  4C Right) . Thus, in agreement with the in vivo data of Fig. 2 , functional HSP60 preferentially associated with adducted ␣KGDH subunits (as well as other modified mitochondrial proteins) and that a proportion of these proteins likely exist as kinetically trapped species.
Because the composition of immune complexes varied, these data argue against simple protein aggregation events for stress protein recognition of DFTAL-modified proteins. For example, HSP60 coprecipitated with E2 o but not E3 o , whereas mtHSP70 precipitated with both (Fig. 4) . These data indicate that mammalian HSP60 and mtHSP70 may interact in the recognition of abnormal proteins and are themselves recognized when adducted. However, we have noted the formation of higher molecular weight complexes, both in vivo and in vitro, which are traditionally associated with protein aggregation events (Figs. 3C and 4) . The possibility remains, therefore, that inactivation of mitochondrial stress proteins will result in the formation of insoluble aggregates that ultimately lead to cell death. The studies presented herein and our earlier work (18) on the submitochondrial distribution of DFTAL proteins suggest the sequence of events represented in Fig. 5 . Reactive metabolites (R ␦ϩ ) from TFEC attack E2 o (which forms the structural inner core of the ␣KGDH complex) and E3 o subunits. This disrupts ␣KGDH quaternary structure, releasing component subunits into differing submitochondrial compartments. Mitochondrial stress protein HSP60 and͞or mtHSP70 recognition follows, thereby determining the subsequent cellular fate of adducted proteins (38, 39) .
Current evidence indicates that the E3 subunit of all multienzyme ketoacid dehydrogenase complexes are identical (40, 41) . Because the reactive acylhalides produced from TFEC metabolism should react indiscriminately with all N -lysine residues in close proximity, it is expected that the E3 subunit of PDH (E3 p ) represents an equally likely target for DFTAL modification. Our observations, however, indicate that E3 p is not adducted and that its enzymatic activity is not inhibited. These results suggest that E3 p was spatially removed from the site of reactive metabolite formation within the mitochondrion.
These studies have indicated that TFEC toxicity is associated with altered mitochondrial ␣-ketoglutarate utilization thereby disrupting the tricarboxylic acid cycle and mitochondrial function. Indeed, congenital defects in the ␣KGDH complex are fatal (42, 43) and E3 o -null mice die at 7.5 days postcoitum as aberrant embryos (41) . Although cross-species extrapolation should be viewed with caution, the relative degree of ␣KGDH inhibition reported herein is comparable to that seen in fibroblasts taken from ␣KGDH-deficient patients (43) . To conclude, TFEC-mediated cell death and organ damage can be accounted for by perturbations to oxidative metabolism, which is fundamental for organism viability.
For more than 20 years, a central tenet in toxicology has been that biologically benign foreign compounds may be converted to reactive metabolites that can then modify cellular macromolecules and alter the structure and͞or function of the target (15) (16) (17) . The covalent binding hypothesis has, consequently, guided the majority of mechanistic studies in the toxicology of reactive intermediates during this time despite a lack of data defining the relative contribution of critical versus inconsequential protein targets. Concurrently, an expansion of knowledge regarding the functions of stress proteins has indicated that this class of proteins is characterized by their selective affinity for nonnative proteins (6-10). These results support the conclusion that in situ covalent modifications of a critical cellular target (i.e., the ␣KGDH complex by TFEC) results in an inhibition of the function of the target. Of equal importance is that the modified target protein is bound by stress proteins that function in the recognition of abnormal fold states. Thus, the physiological roles of mammalian HSP60 and mtHSP70 can now include the recognition of postmaturation reactive-intermediate-modified protein conformations. 
